Your session is about to expire
What is Incivek
Approved as Treatment by the FDA
Telaprevir, also called Incivek, is approved by the FDA for 6 uses which include compensated liver disease and Chronic Hepatitis C Genotype 1 .Effectiveness
When to interrupt dosage
The proposed dosage of Incivek is contingent upon the diagnosed state, including compensated liver disease, Hepatitis C and Treatment Naive. The quantity of dosage fluctuates as per the technique of delivery (e.g. Tablet - Oral or Tablet, film coated - Oral) featured in the table underneath.Warnings
There are 20 known major drug interactions with Incivek.Incivek Novel Uses: Which Conditions Have a Clinical Trial Featuring Incivek?
Currently, there are 2 active clinical trials examining the potential of Incivek in providing Treatment Naive, Interferon Treatment and alleviating Compensated Liver Disease.Incivek Reviews: What are patients saying about Incivek?
Patient Q&A Section about incivek
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Incivek used for?
"Incivek is an antiviral medicine that prevents multiplying virus cells in your body, used in combination with peginterferon alfa and ribavirin to treat hepatitis c in adults."
Why was telaprevir discontinued?
"As of October 2014, Vertex Pharmaceuticals is no longer selling or distributing the drug telaprevir in the United States. The main reason for this is that there are now other available treatments and the demand for this drug has decreased. Telaprevir was originally developed by Vertex Pharmaceuticals and Johnson & Johnson under the name VX-950."
Is telaprevir FDA approved?
"On May 23, 2011, the United States Food and Drug Administration approved INCIVEK⢠(telaprevir) for the treatment of hepatitis c.INCIVEK is a protease inhibitor that works by blocking a protein that the hepatitis C virus needs to multiply. It is used in combination with two other drugs, peginterferon alfa and ribavirin.
The FDA has approved INCIVEK⢠(telaprevir), a protease inhibitor, for the treatment of hepatitis C. INCIVEK works by blocking a protein that the hepatitis C virus needs to multiply. It is used in combination with two other drugs, peginterferon alfa and ribavirin."